Samsung Bioepis First To File EU Lucentis Rival

Confirms SB11 Ranibizumab Biosimilar Candidate Accepted For Filing By EMA

 
• By David Wallace
  
Racers
Samsung Bioepis Is First Off The Marks With A Ranibizumab Filing • Source: Shutterstock

More from Biosimilars

More from Products